Lambda-Shaped Anastomosis with Intravascular Stenting Method for Safe and Effective Lymphaticovenular Anastomosis

吻合 淋巴水肿 医学 显微外科 外科 外科吻合 内科学 癌症 乳腺癌
作者
Takumi Yamamoto,Mitsunaga Narushima,Kazuki Kikuchi,Hidehiko Yoshimatsu,Takeshi Todokoro,Makoto Mihara,Isao Koshima
出处
期刊:Plastic and Reconstructive Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:127 (5): 1987-1992 被引量:153
标识
DOI:10.1097/prs.0b013e31820cf5c6
摘要

Background: Lymphaticovenular anastomosis has become an increasingly common treatment for lymphedema. Supermicrosurgical techniques are essential for the successful performance of lymphaticovenular anastomosis. A positive correlation between the number of lymphaticovenular anastomoses performed and therapeutic efficacy has been reported, and in performing these anastomoses, the establishment of as many bypasses as possible is important. Methods: Forty limbs of 20 patients with lower extremity lymphedema who underwent lymphaticovenular anastomosis in our department were assessed. All cases were performed under local anesthesia using two to four surgical microscopes. A new method of anastomosis, lambda-shaped anastomosis assisted by intravascular stenting, was chosen in required cases. Results: Lymphaticovenular anastomoses resulted in 186 anastomoses on 20 patients with lower extremity lymphedema; the average number of anastomoses per case was 9.3 (range, five to 18). The number of surgical microscopes used ranged from two to four (average, 3.3), and the duration of the operation ranged from 3 to 5 hours (average, 4.1). In the cases of lambda-shaped anastomosis (n = 11), the number of anastomoses was significantly greater than in the cases without lambda-shaped anastomosis (n = 9; 10.2 ± 2.3 versus 8.2 ± 1.4; p < 0.05). Conclusions: Lambda-shaped anastomosis assisted by intravascular stenting is a safe and relatively easy method that can be performed by surgeons with less than 1 year of experience in microsurgery. This in turn allows efficient lymphaticovenular anastomoses to be performed simultaneously by a team of surgeons, resulting in an increased number of bypasses.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hxy发布了新的文献求助10
刚刚
jcae123发布了新的文献求助10
刚刚
Twonej应助Makula采纳,获得30
1秒前
1秒前
科研通AI6.2应助壮观谷冬采纳,获得10
1秒前
1秒前
张zhang发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
科研通AI6.1应助axokyz采纳,获得50
2秒前
星河鹭起发布了新的文献求助10
3秒前
3秒前
3秒前
小二郎应助Null采纳,获得10
3秒前
4秒前
慕青应助小太阳采纳,获得10
4秒前
4秒前
猪猪hero发布了新的文献求助10
4秒前
吴佩泽完成签到,获得积分10
4秒前
大脸猫发布了新的文献求助10
4秒前
5秒前
5秒前
cc发布了新的文献求助10
5秒前
仗炮由纪发布了新的文献求助10
5秒前
zhu笑笑完成签到,获得积分10
6秒前
6秒前
桐桐应助小王采纳,获得10
6秒前
贝卓飞发布了新的文献求助10
7秒前
隐形的凡阳应助cc采纳,获得10
7秒前
jcae123完成签到,获得积分10
8秒前
称心的猫咪完成签到,获得积分20
8秒前
8秒前
屠戮小怪发布了新的文献求助10
8秒前
8秒前
乐乐应助whiskey采纳,获得10
8秒前
诸事皆顺发布了新的文献求助30
8秒前
silence发布了新的文献求助10
8秒前
情怀应助科研通管家采纳,获得10
8秒前
jack应助科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Propeller Design 1000
Weaponeering, Fourth Edition – Two Volume SET 1000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 6000200
求助须知:如何正确求助?哪些是违规求助? 7498212
关于积分的说明 16096717
捐赠科研通 5145129
什么是DOI,文献DOI怎么找? 2757734
邀请新用户注册赠送积分活动 1733491
关于科研通互助平台的介绍 1630784